Susana Ursúa

401 citations
8 papers · 344 indexed · h-index 8
Topics
Cholinesterase and Neurodegenerative Diseases (5 papers)Phosphodiesterase function and regulation (5 papers)Histone Deacetylase Inhibitors Research (4 papers)
Partner nations
SpainChinaNetherlands

In The Last Decade

Susana Ursúa

8 papers receiving 341 citations

Peers

Susana Ursúa
Comparison fields: 5 of 50
  • Molecular Biology 258
  • Pharmacology 105
  • Organic Chemistry 58
  • Physiology 56
  • Neurology 53
Replace María Espelosin with:
María Espelosin Spain
Alise Hyrskyluoto Finland
Patrick Jimonet France
Yasuyuki Mitani Japan
Stefania Ippati Italy
Yafei Xu China
Sandra Sanabria United States
Kristin Jacobsen Sweden
David Thomae Belgium
Filippa Lo Cascio United States
Susana Ursúa relative to María Espelosin Spain María Espelosin's profile →
Citations per field
00.5×1.5×
María Espelosin · 1×
Citations per year

Countries citing papers authored by Susana Ursúa

Since Specialization
Citations

This map shows the geographic impact of Susana Ursúa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susana Ursúa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susana Ursúa more than expected).

Fields of papers citing papers by Susana Ursúa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susana Ursúa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susana Ursúa. The network helps show where Susana Ursúa may publish in the future.

Co-authorship network of co-authors of Susana Ursúa

This figure shows the co-authorship network connecting the top 25 collaborators of Susana Ursúa. A scholar is included among the top collaborators of Susana Ursúa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susana Ursúa. Susana Ursúa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
#WorkIndexed citations
1 8
2 28
3 76
4 35
5 58
6 35
7 31
8 73

About Susana Ursúa

Susana Ursúa is a scholar working on Biological Psychiatry, Pharmacology and Neurology, having authored 8 papers that have together received 344 indexed citations. Recurring topics across this work include Cholinesterase and Neurodegenerative Diseases (5 papers), Phosphodiesterase function and regulation (5 papers) and Histone Deacetylase Inhibitors Research (4 papers). The work is most often cited by research in Pharmacology (105 citations), Genetics (40 citations) and Molecular Biology (258 citations). Susana Ursúa has collaborated with scholars based in Spain, China and Netherlands. Frequent co-authors include Mar Cuadrado‐Tejedor, María Espelosin, Ana Garcı́a-Osta, Marta Pérez-González, Ana Ugarte, Obdulia Rabal, Elena Sáez, Musheng Xu, Julen Oyarzábal and Irene de Miguel. Their work appears in journals such as International Journal of Molecular Sciences, Journal of Medicinal Chemistry and Progress in Neurobiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026